Sicart Associates’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-443
| Closed | -$475K | – | 110 |
|
|
2019
Q4 | $475K | Sell |
443
-600
| -58% | -$643K | 0.16% | 72 |
|
|
2019
Q3 | $964K | Hold |
1,043
| – | – | 0.32% | 43 |
|
|
2019
Q2 | $1.18M | Hold |
1,043
| – | – | 0.48% | 40 |
|
|
2019
Q1 | $1.42M | Hold |
1,043
| – | – | 0.6% | 35 |
|
|
2018
Q4 | $1.21M | Hold |
1,043
| – | – | 0.58% | 35 |
|
|
2018
Q3 | $1.58M | Hold |
1,043
| – | – | 0.76% | 32 |
|
|
2018
Q2 | $1.63M | Sell |
1,043
-200
| -16% | -$313K | 0.86% | 28 |
|
|
2018
Q1 | $1.44M | Hold |
1,243
| – | – | 0.86% | 31 |
|
|
2017
Q4 | $1.47M | Hold |
1,243
| – | – | 0.78% | 39 |
|
|
2017
Q3 | $1.67M | Hold |
1,243
| – | – | 1.2% | 25 |
|
|
2017
Q2 | $1M | Hold |
1,243
| – | – | 0.73% | 34 |
|
|
2017
Q1 | $766K | Buy |
+1,243
| New | +$766K | 0.55% | 43 |
|